Stock

Alkem Laboratories — MTF Book

ALKEM · Alkem Laboratories Limited
Health Technology

Daily Margin Trading Facility book for Alkem Laboratories across NSE and BSE, from 01 Aug 2017. All figures in ₹ crore, derived from exchange public disclosures.

What is Alkem Laboratories’s MTF book?

Alkem Laboratories Limited (ALKEM) has ₹28 crore funded under Margin Trading Facility across NSE and BSE as of 23 Oct 2026 — 0.02% of India’s MTF book, ranking #885. Over 1M (the last 30 trading days) the funded value has fallen 13.1%, with the number of shares under margin down 12.6%.

Funded value
₹28 Cr
as of 23 Oct 2026
Rank in book
#885
1,661 days tracked
Share of book
0.02%
of the whole NSE + BSE book
Peak funded
₹58 Cr
on 10 Jul 2025
Largest single-day addition
+₹16 Cr
on 11 Aug 2023
Largest single-day unwind
−₹10 Cr
on 13 Aug 2025
Free-float market cap
₹29,752 Cr
full market cap ₹59,149 Cr · 50.3% free float · Mid cap
MTF share of free float
0.09%
0.2× the median mid cap · 0.1× the Health Technology median

Share of free float on margin, month by month

Shares under margin at each month-end as a share of free-float shares, using that month-end’s share count and the free-float filing public at the time. It counts shares, not value, so a price move does not move it by itself.

0.02%0.08%0.14%0.21%Apr 2024Oct 2026
View as table: share of free float on margin24 months
Month-end% of free float
23 Oct 20260.085%
30 Sep 20260.084%
31 Aug 20260.087%
31 Jul 20260.058%
29 Jun 2026†0.066%
29 May 20260.062%
30 Apr 20260.057%
19 Mar 2026†0.042%
24 Feb 2026†0.043%
25 Nov 2025†0.042%
31 Oct 20250.041%
30 Sep 20250.048%
29 Aug 20250.068%
31 Jul 20250.114%
30 Jun 20250.186%
30 May 20250.105%
30 Apr 20250.107%
28 Mar 20250.064%
28 Feb 20250.088%
31 Jan 20250.076%
05 Jul 2024†0.106%
27 Jun 2024†0.100%
03 May 2024†0.096%
30 Apr 20240.093%

† Not the month’s last trading day: the last day the stock was in the archive that month (before 11 Nov 2025 the archive kept only the 500 largest positions).

Dated events

NSE & BSE split

How ALKEM’s funded book divides across the two exchanges, as of 23 Oct 2026.
NSE
NSE ₹27 Cr · 96.4%BSE ₹1 Cr · 3.6%

MTF vs Price

Margin-funded outstanding for ALKEM in ₹ crore against the closing price, adjusted for splits and bonuses. Each window uses the same reference date as the table below, so the two agree. Funded value moves with the price on its own, so the line under the chart reads the share count instead — that is what shows whether more stock is genuinely being borrowed against.
MTF book (₹ Cr)

Price and liquidity

Adjusted for splits and bonuses, so a change across a corporate action reflects the market rather than the share count.
Last close
₹4,947.00
as of 23 Oct 2026
Price, 1M
−3.7%
adjusted for splits and bonuses
Delivery, 20-day avg
58.0%
of traded volume actually settled
Sessions to unwind
1
of average deliverable volume
Shares under margin divided by average daily deliverable volume over the last 20 sessions.

Book, shares and price by window

Funded value moves with the price on its own, so the share count is what shows whether more stock is actually being borrowed against. The last column reads the two together.
WindowBook ΔBook %SharesPriceReading
1D−₹0−1.8%−1.8%
−917
−1.3%unwinding as it falls
10D+₹3+10.3%+11.5%
+5,275
−5.8%building as it falls
1M−₹4−13.1%−12.6%
−7,344
−4.5%unwinding as it falls
3Mnot enough history
6M+₹13+83.5%+86.6%
+23,678
−10.4%building as it falls
1Y+₹15+114.6%+114.6%
+27,237
−10.6%building as it falls

Shares under margin

Number of shares funded via MTF over time (NSE + BSE combined).

Rank trajectory

Where ALKEM has sat in the funded-value ranking each day (1 = most funded). Lower is more prominent.

ALKEM — last 30 trading days

Combined NSE + BSE funded value, day-on-day change, share of the whole book, and rank. Newest first.
DateCombined (₹ Cr)Day Δ (₹ Cr)% of bookRank
23 Oct 202628−₹00.02%885
22 Oct 202628+₹00.02%884
21 Oct 202628+₹00.02%893
19 Oct 202628+₹00.02%899
16 Oct 202628+₹10.02%906
15 Oct 202627+₹10.02%916
14 Oct 202626+₹00.02%936
13 Oct 202626−₹00.02%938
12 Oct 202626+₹10.02%936
09 Oct 202625−₹00.02%955
08 Oct 202625−₹10.02%950
07 Oct 202626−₹10.02%934
06 Oct 202627−₹10.02%921
05 Oct 202628+₹00.02%905
01 Oct 202627−₹00.02%914
30 Sep 202628+₹00.02%912
29 Sep 202627−₹00.02%920
28 Sep 202628−₹10.02%912
25 Sep 202628+₹00.02%894
24 Sep 202628+₹00.02%903
23 Sep 202628−₹10.02%906
22 Sep 202629+₹00.02%884
21 Sep 202629+₹00.02%886
18 Sep 202629−₹10.02%886
17 Sep 202629−₹10.02%877
16 Sep 202630+₹00.02%863
15 Sep 202630−₹10.02%866
11 Sep 202632−₹00.02%848
10 Sep 202632+₹00.02%847
09 Sep 202632—0.02%847

ALKEM within Health Technology

Ranked #53 of 61 funded Health Technology stocks, carrying 0.4% of that sector’s margin book. Its 0.09% of free float on margin is 0.1× the sector median of 0.90%. Nearest names by funded value:
#StockMTF book (₹ Cr)% of sector% of free floatBook, 1M
51WINDLASWindlas Biotech₹310.5%4.36%+5.7%
52AARTIDRUGSAarti Drugs₹310.5%1.73%+1.3%
53ALKEMAlkem Laboratories₹280.4%0.09%−13.1%
54ASTRAZENAstraZeneca Pharma India₹270.4%0.57%−13.8%
55RUBICONRubicon Research₹260.4%0.25%−15.6%

All Health Technology stocks and how the sector has moved →

Disclaimer. Data sourced from daily margin trading disclosure provided by NSE and BSE. This website and page are meant for educational and information only — not investment advice. MTF is leveraged and can amplify losses. Rules, margins, rates and eligible-stock lists change; verify current details with your broker and SEBI/exchange circulars. IndiaMTF.com is not a SEBI-registered intermediary, broker, or investment adviser and has no affiliation with SEBI, NSE or BSE. Figures are reproduced from publicly disclosed exchange data, may be delayed or revised, and should be independently verified before any trading decision. Consult a SEBI-registered investment adviser before investing.